Physician profile
Candice Nipp
NPI 1699128595
$3,386.22
in general payments reported to CMS, 2019-2025
24 companies · $582 in 2025
The $582 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $585 · 2022: $1,029 · 2023: $702 · 2024: $488 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $702.02 | 2021-2025 | Lifevest |
| Abbott Laboratories | $587.96 | 2021-2024 | Jot Dx, Cardiomems |
| Merck Sharp & Dohme LLC | $384.09 | 2021-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $367.05 | 2021-2025 | |
| Pfizer INC. | $223.49 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $188.01 | 2021-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $159.37 | 2021-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $133.55 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.42 | 2022-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $71.37 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $61.96 | 2021-2022 | |
| Amgen INC. | $57.89 | 2022-2025 | Repatha, Repatha |
| Inari Medical, INC. | $57.51 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vital Connect, INC | $48.25 | 2025 | Vitalpatch Rtm |
| Philips North America LLC | $42.01 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $38.29 | 2025 | Sapien 3 Ultra Resilia |
| Angiodynamics, INC. | $33.27 | 2023 | Alphavac |
| Boston Scientific Corporation | $25.68 | 2023 | Varithena Administration Pack |
| Scpharmaceuticals INC. | $21.60 | 2023 | |
| Novo Nordisk INC | $18.97 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.57 | 2023 | Inpefa |
| Medtronic, INC. | $16.13 | 2024 | Venaseal |
| Cordis US Corp. | $13.95 | 2025 | Rain Sheath |
| Shockwave Medical, INC | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Nipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.